Treatment for Myasthenia Gravis with Ocular Involvement and Diplopia
Start with oral pyridostigmine bromide 2-4 times daily as first-line treatment, but if symptoms persist or response is inadequate (which occurs in approximately 50% of ocular myasthenia cases), escalate to oral corticosteroids using an alternate-day regimen, as 66-85% of patients respond positively to steroids. 1
Treatment Algorithm
First-Line Therapy
- Pyridostigmine bromide administered orally 2-4 times daily 1, 2
- However, recognize that approximately half of patients with strabismus-associated myasthenia show minimal response to this agent alone 1
- In the pyridostigmine-only group, resolution of primary gaze diplopia occurs in only 6.9% at 1 month, and downgaze diplopia resolves in only 17.2% 3
Second-Line Therapy: Corticosteroids
When pyridostigmine fails to adequately control symptoms:
- Prednisone 50-60 mg daily, increased gradually over 5 days, then tapered to 10 mg or lower as tolerated 1, 3
- Use alternate-day regimen to minimize side effects 2
- Critical warning: Increase steroid doses slowly due to risk of precipitating myasthenic crisis 4
Efficacy data strongly favors steroids: At 1 month, prednisone resolves primary gaze diplopia in 73.5%, downgaze diplopia in 75.5%, and unilateral ptosis in 85.7% of patients, with benefits persisting at 12 and 24 months 3
Third-Line: Steroid-Sparing Immunosuppression
If high steroid doses are required or symptoms remain poorly controlled:
- Azathioprine as steroid-sparing agent 1, 2
- Consider efgartigimod alfa-fcab (FDA-approved) for patients who test positive for anti-acetylcholine receptor antibodies 1
Thymectomy Considerations
- Always indicated if thymoma is present 1, 2
- May substantially reduce symptoms in certain subpopulations and potentially prevent generalization of disease 2
Important Clinical Pitfalls
Prism Limitations
Diplopia and strabismus in myasthenia are highly variable and not readily remedied with prisms 1. The fluctuating nature of the misalignment makes prism correction challenging.
Surgical Timing
- Strabismus surgery should only be considered after 2-3 years of medical treatment when disease has achieved remission or stabilization 1
- Requires stabilized primary deviation
- Multiple surgeries may be necessary
- Anesthetic caution: Use care with anesthetic agents if any evidence of respiratory muscle weakness exists 1
Response Expectations and Recurrence
Among prednisone-responsive patients, recurrences are common—33 recurrences occurred in 26 of 51 responsive patients in one study 3. Approximately 12 patients achieved remission with prednisone treatment 3.
Multidisciplinary Management
Diagnosis and management require coordination between an experienced ophthalmologist and a treating neurologist 1. Referral to neuro-ophthalmology and potentially general surgery (for thymectomy) is often indicated 1.
Monitoring for Generalization
Remain vigilant for comorbidities such as respiratory distress that might indicate progression to generalized myasthenia gravis 1. Both steroids and thymectomy may modify disease course and prevent generalization 2.
Alternative/Adjunctive Approaches
For select cases with persistent isolated diplopia despite systemic therapy, local periocular or extraocular muscle dexamethasone injections (weekly for 4-6 weeks) have shown 85.7% symptom relief in small studies 5, 6, though this remains an investigational approach requiring close ophthalmic monitoring.